Topical intranasal corticosteroids in 4-11 year old children with persistent bilateral otitis media with effusion in primary care: Double blind randomised placebo controlled trial

Ian Williamson*, Sarah Benge, Sheila Barton, Stavros Petrou, Louise Letley, Nicky Fasey, Mark Haggard, Paul Little

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

31 Citations (Scopus)

Abstract

Objective: To determine the clinical effectiveness of topical intranasal corticosteroids in children with bilateral otitis media with effusion. Design: Double blind randomised placebo controlled trial. Setting: 76 Medical Research Council General Practice Research Framework practices throughout the United Kingdom, between 2004 and 2007. Participants: 217 children aged 4-11 years who had at least one practice recorded episode of otitis media or a related ear problem in the previous 12 months, and with bilateral otitis media with effusion confirmed by a research nurse using otoscopy plus micro-tympanometry (B/B or B/C2, modified Jerger types). Intervention: Mometasone furoate 50 μg or placebo spray given once daily into each nostril for three months. Main outcome measures: Proportions of children cured of bilateral otitis media with effusion assessed with tympanometry (C1 or A type) at one month (primary end point), three months, and nine months; adverse events; three month diary symptoms. Results: 41% (39/96) of the topical steroid group and 45% (44/98) of the placebo group were cured in one or both ears at one month (difference favouring placebo 4.3% (95% confidence interval -9.3% to 18.1%). Poisson regression was done with adjustment for four prespecified covariates (clinical severity, P=0.003; atopy, P=0.67; age, P=0.92; season, P=0.71). The adjusted relative risk at one month was 0.97 (95% confidence interval 0.74 to 1.26). At three months, 58% of the topical steroid group and 52% of the placebo group were cured (relative risk 1.23, 0.84 to 1.80). Diary symptoms did not differ between the two groups, and no significant harms were reported. Conclusions: Topical steroids are unlikely to be an effective treatment for otitis media with effusion in general practice. High rates of natural resolution occurred by 1-3 months. Trial registration: Current Controlled Trials ISRCTN38988331; National Research Register NO575123823; MREC 03/11/073.

Original languageEnglish
Article numberb4984
Pages (from-to)83
Number of pages1
JournalBritish Medical Journal
Volume339
DOIs
Publication statusPublished - 9 Jan 2010
Externally publishedYes

Fingerprint

Dive into the research topics of 'Topical intranasal corticosteroids in 4-11 year old children with persistent bilateral otitis media with effusion in primary care: Double blind randomised placebo controlled trial'. Together they form a unique fingerprint.

Cite this